275 related articles for article (PubMed ID: 22836867)
1. Nuclear fibroblast growth factor 2 (FGF2) isoforms inhibit bone marrow stromal cell mineralization through FGF23/FGFR/MAPK in vitro.
Xiao L; Esliger A; Hurley MM
J Bone Miner Res; 2013 Jan; 28(1):35-45. PubMed ID: 22836867
[TBL] [Abstract][Full Text] [Related]
2. FGF23 Neutralizing Antibody Ameliorates Hypophosphatemia and Impaired FGF Receptor Signaling in Kidneys of HMWFGF2 Transgenic Mice.
Du E; Xiao L; Hurley MM
J Cell Physiol; 2017 Mar; 232(3):610-616. PubMed ID: 27306296
[TBL] [Abstract][Full Text] [Related]
3. FGF23 Neutralizing Antibody Partially Improves Bone Mineralization Defect of HMWFGF2 Isoforms in Transgenic Female Mice.
Xiao L; Homer-Bouthiette C; Hurley MM
J Bone Miner Res; 2018 Jul; 33(7):1347-1361. PubMed ID: 29502359
[TBL] [Abstract][Full Text] [Related]
4. Nuclear isoforms of fibroblast growth factor 2 are novel inducers of hypophosphatemia via modulation of FGF23 and KLOTHO.
Xiao L; Naganawa T; Lorenzo J; Carpenter TO; Coffin JD; Hurley MM
J Biol Chem; 2010 Jan; 285(4):2834-46. PubMed ID: 19933269
[TBL] [Abstract][Full Text] [Related]
5. Bone proteins PHEX and DMP1 regulate fibroblastic growth factor Fgf23 expression in osteocytes through a common pathway involving FGF receptor (FGFR) signaling.
Martin A; Liu S; David V; Li H; Karydis A; Feng JQ; Quarles LD
FASEB J; 2011 Aug; 25(8):2551-62. PubMed ID: 21507898
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of fibroblast growth factor 23 suppresses osteoblast differentiation and matrix mineralization in vitro.
Wang H; Yoshiko Y; Yamamoto R; Minamizaki T; Kozai K; Tanne K; Aubin JE; Maeda N
J Bone Miner Res; 2008 Jun; 23(6):939-48. PubMed ID: 18282132
[TBL] [Abstract][Full Text] [Related]
7. FGF and ERK signaling coordinately regulate mineralization-related genes and play essential roles in osteocyte differentiation.
Kyono A; Avishai N; Ouyang Z; Landreth GE; Murakami S
J Bone Miner Metab; 2012 Jan; 30(1):19-30. PubMed ID: 21678127
[TBL] [Abstract][Full Text] [Related]
8. FGF receptor inhibitor BGJ398 partially rescues osteoarthritis-like phenotype in older high molecular weight FGF2 transgenic mice via multiple mechanisms.
Hurley MM; Coffin JD; Doetschman T; Valera C; Clarke K; Xiao L
Sci Rep; 2022 Sep; 12(1):15968. PubMed ID: 36153352
[TBL] [Abstract][Full Text] [Related]
9. FGFR Inhibitor Ameliorates Hypophosphatemia and Impaired Engrailed-1/Wnt Signaling in FGF2 High Molecular Weight Isoform Transgenic Mice.
Du E; Xiao L; Hurley MM
J Cell Biochem; 2016 Sep; 117(9):1991-2000. PubMed ID: 26762209
[TBL] [Abstract][Full Text] [Related]
10. Expression of the high molecular weight fibroblast growth factor-2 isoform of 210 amino acids is associated with modulation of protein kinases C delta and epsilon and ERK activation.
Gaubert F; Escaffit F; Bertrand C; Korc M; Pradayrol L; Clemente F; Estival A
J Biol Chem; 2001 Jan; 276(2):1545-54. PubMed ID: 11031252
[TBL] [Abstract][Full Text] [Related]
11. Knockout of nuclear high molecular weight FGF2 isoforms in mice modulates bone and phosphate homeostasis.
Homer-Bouthiette C; Doetschman T; Xiao L; Hurley MM
J Biol Chem; 2014 Dec; 289(52):36303-14. PubMed ID: 25389287
[TBL] [Abstract][Full Text] [Related]
12. BMP-2 differentially modulates FGF-2 isoform effects in osteoblasts from newborn transgenic mice.
Sabbieti MG; Agas D; Marchetti L; Coffin JD; Xiao L; Hurley MM
Endocrinology; 2013 Aug; 154(8):2723-33. PubMed ID: 23715864
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of FGFR Signaling Partially Rescues Hypophosphatemic Rickets in HMWFGF2 Tg Male Mice.
Xiao L; Du E; Homer-Bouthiette C; Hurley MM
Endocrinology; 2017 Oct; 158(10):3629-3646. PubMed ID: 28938491
[TBL] [Abstract][Full Text] [Related]
14. Regulation of mRNA expression of matrix extracellular phosphoglycoprotein (MEPE)/ osteoblast/osteocyte factor 45 (OF45) by fibroblast growth factor 2 in cultures of rat bone marrow-derived osteoblastic cells.
Zhang GX; Mizuno M; Tsuji K; Tamura M
Endocrine; 2004 Jun; 24(1):15-24. PubMed ID: 15249699
[TBL] [Abstract][Full Text] [Related]
15. Fibroblast growth factor 23 (FGF23) and alpha-klotho stimulate osteoblastic MC3T3.E1 cell proliferation and inhibit mineralization.
Shalhoub V; Ward SC; Sun B; Stevens J; Renshaw L; Hawkins N; Richards WG
Calcif Tissue Int; 2011 Aug; 89(2):140-50. PubMed ID: 21633782
[TBL] [Abstract][Full Text] [Related]
16. Excessive Osteocytic Fgf23 Secretion Contributes to Pyrophosphate Accumulation and Mineralization Defect in Hyp Mice.
Murali SK; Andrukhova O; Clinkenbeard EL; White KE; Erben RG
PLoS Biol; 2016 Apr; 14(4):e1002427. PubMed ID: 27035636
[TBL] [Abstract][Full Text] [Related]
17. Fibroblast growth factor 2 induction of the osteocalcin gene requires MAPK activity and phosphorylation of the osteoblast transcription factor, Cbfa1/Runx2.
Xiao G; Jiang D; Gopalakrishnan R; Franceschi RT
J Biol Chem; 2002 Sep; 277(39):36181-7. PubMed ID: 12110689
[TBL] [Abstract][Full Text] [Related]
18. Fibroblast Growth Factor 2 High Molecular Weight Isoforms in Dentoalveolar Mineralization.
Millington G; Joseph J; Xiao L; Vijaykumar A; Mina M; Hurley MM
Calcif Tissue Int; 2022 Jan; 110(1):93-103. PubMed ID: 34245331
[TBL] [Abstract][Full Text] [Related]
19. FGF23 Regulates Wnt/β-Catenin Signaling-Mediated Osteoarthritis in Mice Overexpressing High-Molecular-Weight FGF2.
Meo Burt P; Xiao L; Hurley MM
Endocrinology; 2018 Jun; 159(6):2386-2396. PubMed ID: 29718273
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of the DMP1 C-terminal fragment stimulates FGF23 and exacerbates the hypophosphatemic rickets phenotype in Hyp mice.
Martin A; David V; Li H; Dai B; Feng JQ; Quarles LD
Mol Endocrinol; 2012 Nov; 26(11):1883-95. PubMed ID: 22930691
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
